David P. Cosgrove

发表

Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

B. Vogelstein, K. Polyak, D. Gorkin, 2010, Oncogene.

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

T. Pawlik, I. Kamel, N. Bhagat, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features

B. Naini, L. Wood, I. Kamel, 2013, Modern Pathology.

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

Hiroyuki Konishi, David Cosgrove, Yuko Konishi, 2011, Proceedings of the National Academy of Sciences.

The PIK3CA gene as a mutated target for cancer therapy.

B. Park, J. Gustin, D. Cosgrove, 2008, Current cancer drug targets.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

T. Pawlik, I. Kamel, N. Bhagat, 2013, Journal of the American College of Surgeons.

Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

T. Pawlik, I. Kamel, J. Herman, 2014, Hepatobiliary surgery and nutrition.

Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making

M. Choti, T. Pawlik, L. Diaz, 2012, Annals of Surgical Oncology.

Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.

T. Pawlik, I. Kamel, K. Hong, 2016, Contemporary clinical trials.

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

M. Choti, T. Pawlik, M. Torbenson, 2013, Gastrointestinal cancer research : GCR.

Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

M. Choti, A. Ejaz, G. Spolverato, 2015, JAMA surgery.

Cadmium Exposure and Liver Disease among US Adults

T. Pawlik, J. Herman, O. Hyder, 2013, Journal of Gastrointestinal Surgery.

Pattern of distant metastases in colorectal cancer: a SEER based study

Dajun Yang, R. Xu, M. Qiu, 2015, Oncotarget.

Intrahepatic cholangiocarcinoma: management options and emerging therapies.

David Cosgrove, Timothy M Pawlik, Robert Anders, 2013, Journal of the American College of Surgeons.

Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest

T. Pawlik, I. Kamel, A. Demirjian, 2011, Journal of Gastrointestinal Surgery.

Knockin of mutant PIK3CA activates multiple oncogenic pathways

B. Park, K. Bachman, H. Konishi, 2009, Proceedings of the National Academy of Sciences.

Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies

Rebecca M. Dodson, T. Pawlik, I. Kamel, 2013, Journal of Gastrointestinal Surgery.

Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis

A. Ejaz, G. Spolverato, T. Pawlik, 2015, Journal of Gastrointestinal Surgery.

Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis

A. Ejaz, G. Spolverato, T. Pawlik, 2015, World Journal of Surgery.

Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Rebecca M. Dodson, T. Pawlik, I. Kamel, 2013, Journal of the American College of Surgeons.

Trends and Patterns of Utilization in Post-treatment Surveillance Imaging Among Patients Treated for Hepatocellular Carcinoma

Rebecca M. Dodson, T. Pawlik, I. Kamel, 2013, Journal of Gastrointestinal Surgery.

Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US

T. Pawlik, I. Kamel, O. Hyder, 2013, Journal of Gastrointestinal Surgery.

The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma

A. Ejaz, G. Spolverato, Yuhree Kim, 2015, World Journal of Surgery.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2013, Radiology.

Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model.

A. Ejaz, G. Spolverato, Yuhree Kim, 2015, Surgery.

Diabetes and pancreatic cancer.

H. Yeh, R. Kalyani, Erica Hall, 2013, Current problems in cancer.

Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

T. Pawlik, I. Kamel, N. Bhagat, 2013, Journal of the American College of Surgeons.

Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

M. Choti, A. Ejaz, G. Spolverato, 2015, JAMA surgery.